跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,186 条关于
“Polyrizon Ltd.”
全部
9,186
临床试验
1,686
药物
1,492
机构
4,085
资讯
1,923
去年
Polyrizon Strengthens Leadership with Appointment of Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
去年
Polyrizon Secures Manufacturing Agreement with Eurofins CDMO for PL-14 Allergy Blocker
去年
Polyrizon Partners to Develop Novel Intranasal Delivery System for Psychedelic Therapeutics
去年
Polyrizon Advances PL-14 Allergy Blocker with Successful Safety Study and Clinical Strategy
9个月前
Polyrizon Submits FDA Pre-Request for PL-16 Viral Blocker with Over 90% Efficacy Against Respiratory Viruses
9个月前
Polyrizon's Naloxone Hydrogel Shows Superior Nasal Adhesion in Preclinical Study, Potentially Improving Overdose Reversal
去年
Polyrizon's Intranasal Barrier Technology Shows Promise Against Respiratory Viruses and Allergens
去年
PromarkerEso Blood Test Shows 94% Accuracy in Esophageal Cancer Detection
2年前
BioLineRx's APHEXDA Gains Momentum in Stem Cell Mobilization for Multiple Myeloma
2年前
Epsilogen Completes Series B Expansion to Advance IgE Antibody Therapy for Ovarian Cancer
第 1 页,共 193 页
上一页
下一页